Thus, in light of the widespread application of therapeutic strategies based on an anti-folate treatment against TYMS, such as pemetrexed in MPM [19] or 5-FU in CRC [9], and the unprecedented role of natural compounds in tumor prevention and suppression, we investigated the molecular mechanisms of TYMS expression regulation upon EPE treatment. The gene discussed is TYMS; the disease is colorectal carcinoma.